Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million in Executed Financings and M&A, Respectively TYLER, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that Zeev Rotstein, M.D., a current board member and internationally recognized health system leader, has been named Chairman of the Board, succeeding David Johnson

AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers  See Ask Oscar in action: https://envuemed.com/ask-oscar/#video TYLER, Texas, June 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today introduced ‘Ask Oscar™', a new AI-powered training platform designed to address one of the biggest barriers to adoption of medical technology: training. The platform marks the Company's transformation from a medical device maker int

TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that a major U.S. academic health network has expanded its use of the ENvue™ Navigation Platform into its American Burn Association-verified burn intensive care unit, marking the second deployment within the same health system and expanding access to ENvue's technology for a particularly vulnerable patient population. "We believe that this health network's decision to bring the ENvue Navigation Platform into their burn ICU speaks directly to the clinica

Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging Validates Value of Integrating ENvue Navigation Platform as Standard of Care in U.S. Hospitals, Saving Costs on Nursing Hours, Imaging, and Patient Complications Findings Published in Official Journal of the American Association of Critical Care Nurses TYLER, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that an independent, peer-reviewed study has

TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the Company will participate as an exhibitor at the American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition ("AACN NTI") 2026, taking place May 21–22, 2026. Recognized as the largest critical care nursing conference in the United States, AACN NTI brings together thousands of frontline nurses, nurse leaders, educators and healthcare professionals from leading hospitals and healthcare systems nationwide. "Cr

TYLER, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced a three-year contract renewal by a leading integrated nonprofit health system operating 12 hospitals across Virginia and North Carolina. The ENvue™ Navigation Platform has been adopted as the standardized protocol for bedside enteral feeding tube placement across all hospitals within the network. Standardization at the health system level represents significant commercial validation in medical device adoption. Unlike contracted access — which makes

TYLER, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 17/025,969, covering a novel drug delivery system utilizing the Company's proprietary surface acoustic wave (SAW) technology to enhance transdermal delivery of cannabinoid-based therapeutics. The allowed claims provide broad intellectual property protection across multiple components of the combined SAW ultrasound and cannabino

TYLER, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced a three-year purchasing agreement renewal with the Group Purchasing Organization ("GPO") for one of the largest non-profit health systems in the United States, operating over 90 hospitals across 17 states. The renewal ensures that hospitals and care sites within the network can access the ENvue™ Navigation Platform through established contracting pathways, without the need for individual procurement processes at the facility level.Contracted access

TYLER, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced that a Virginia-based, 255-bed nonprofit regional medical center affiliated with the Mayo Clinic Care Network is now using the ENvue™ Navigation Platform. The hospital is now performing feeding tube placement through a nursing-led bedside model, transitioning procedures from interventional radiology to trained clinical staff at the point of care. "The transition to a nursing-led bedside model

TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today issued the following stockholder letter and corporate update: Dear Stockholders, 2025 was a transformative year for ENvue Medical. Today, our Company is a commercially active medtech business trading on the Nasdaq Capital Market under the ticker "FEED." ENvue's mission is to improve patient safety and clinical workflow through proprietary technologies that deliver real-time guidance, intelligent naviga

4 - ENvue Medical, Inc. (0001326706) (Issuer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

3/A - ENvue Medical, Inc. (0001326706) (Issuer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

PRE 14A - ENvue Medical, Inc. (0001326706) (Filer)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

EFFECT - ENvue Medical, Inc. (0001326706) (Filer)

424B3 - ENvue Medical, Inc. (0001326706) (Filer)

S-3 - ENvue Medical, Inc. (0001326706) (Filer)

10-Q - ENvue Medical, Inc. (0001326706) (Filer)

NT 10-Q - ENvue Medical, Inc. (0001326706) (Filer)

144 - ENvue Medical, Inc. (0001326706) (Subject)

10-K - ENvue Medical, Inc. (0001326706) (Filer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million in Executed Financings and M&A, Respectively TYLER, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that Zeev Rotstein, M.D., a current board member and internationally recognized health system leader, has been named Chairman of the Board, succeeding David Johnson

TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue's U.S. commercialization strategy, with a focus on expanding its existing presence in 38 hospitals and accelerating revenue across the Company's enteral platform. "Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships th

ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team. David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company's unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping h